stomach cancer
Researchers are investigating whether immunotherapy benefits people with esophageal and gastric cancers that have not spread to distant organs.
A study is validating the use of genomic sequencing to predict the likelihood that patients with gastric cancer will derive benefit from therapies.
During Stomach Cancer Awareness Month, recognized in November, learn about this disease and the symptoms and risk factors that could help you stay alert.